Clinical activity of mammalian target of rapamycin inhibitors in solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical activity of mammalian target of rapamycin inhibitors in solid tumors

Published:2011-05-04 Issue:2 Volume:6 Page:69-94
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Alvarado Yesid,Mita Monica M.,Vemulapalli Sushma,Mahalingam Devalingam,Mita Alain C.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-011-0178-5.pdf

Reference206 articles.

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70

2. Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9(8):550–562

3. Raman M, Cobb MH (2003) MAP kinase modules: many roads home. Curr Biol 13(22):R886–R888

4. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science (New York, NY) 296(5573):1655–1657

5. Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, Katada T (1997) Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 272(39):24252–24256

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shrimp Lipids Inhibit Migration, Epithelial–Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression;Biomedicines;2024-03-25

2. CADD Approaches in Anticancer Drug Discovery;Interdisciplinary Biotechnological Advances;2023

3. Management of pancreatic kaposiform hemangioendothelioma with sirolimus in a pediatric patient: a case report and literature review;Translational Pediatrics;2022-08

4. The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines;Molecular Biology Reports;2021-08

5. Sirolimus for the treatment of kaposiform hemangioendothelioma: In a trough level‐dependent way;The Journal of Dermatology;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3